Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SNNA - The Verdict On Sienna Biopharmaceuticals


SNNA - The Verdict On Sienna Biopharmaceuticals

People who LIKE movies have a favorite. People who LOVE movies couldn't possibly choose.” ? Nicole Yatsonsky

Today we look at a small developmental firm with multiple shots on goal but that has largely destroyed shareholder value since coming public. The shares seem to have stabilized in 2019 and a Busted IPO Forum member requested a deeper dive on this small cap concern. Our investment analysis follows in the paragraphs below.

Company Overview:

Sienna Biopharmaceuticals (SNNA) IPO’d in 2017 and is a California-based clinical-stage biopharmaceutical company focused on developing and advancing targeted,

Read more ...

Stock Information

Company Name: Sienna Biopharmaceuticals Inc.
Stock Symbol: SNNA
Market: NASDAQ
Website: SiennaBio.com

Menu

SNNA SNNA Quote SNNA Short SNNA News SNNA Articles SNNA Message Board
Get SNNA Alerts

News, Short Squeeze, Breakout and More Instantly...